Yanghee Woo, M.D.

[email protected]
(877) 460-4673
Yanghee Woo, M.D.
Surgical Oncologist
Clinical Expertise
  • Stomach Cancer Surgery
  • Gastroesophageal Junction Cancer Surgery
  • Robotic Surgery for Stomach, Gastroesophageal Junction, Pancreatic and Splenic Tumors
  • Surgery for GIST and Carcinoid (neuroendocrine Tumors) of the Stomach
  • Surgery for Retroperitoneal Lymph Node Removal
  • HIPEC — Hyperthermic (or Heated) Intraperitoneal Chemotherapy
  • PIPAC — Pressurized Intraperitoneal Aerosol Chemotherapy
Research Area
  • Immune Biomarker for Diagnosis and Treatment of Gastric and Other GI Cancers
  • Oncolytic Viruses for Diagnosis and Treatment of Gastric, Pancreatic and Other GI Cancers
  • Surgical Innovation for Enhancing Both Oncologic and Quality of Life Outcomes
  • Disparities that Adversely Impact the Stomach Health of Ethnic Minorities
Other Languages Spoken
Korean
Academic Appointments
  • Director, Gastroenterology Minimally Invasive Therapy Program
  • Associate Professor, Division of Surgical Oncology, Department of Surgery
  • Vice Chair, International Affairs
Clinical Teams
Stomach (Gastric) Cancer
Surgery — Surgical Oncology
Upper GI & Mixed Tumor Surgery
Gene Surgery Lab
Peritoneal Surface Malignancies
Research Teams
Gene Surgery
Additional Contacts
  • Referring Physicians/Colleagues
    (626) 218-0220

Yanghee Woo, M.D., is an internationally recognized surgeon scientist with expertise in robotic surgery and gastric cancer. She is sought by patients for her surgical talent, candid bedside manner and compassionate care. As a leader in her field, Dr. Woo has dedicated her unique perspective, training, and expertise to bring the best of surgical innovation and medical discoveries to transform cancer care of her patients and cancer patients worldwide. Dr. Woo has been awarded the “Illuminator Award” by Hope for Stomach Cancer for her visionary work in stomach cancer and the “Community Leader in Medicine Award” by the Korean American Federation of LA for her efforts to eliminate disparities in cancer care in our communities.

 

Dr. Woo's education, training and experiences have equipped her well as an exemplary cancer surgeon. She graduated from Princeton University with a B.A. in political science, received her M.D. from Drexel University Medical School, completed the general surgery residency at Columbia University Medical Center (CUMC), the research fellowship at Memorial Sloan Kettering Cancer Center (mentored by Yuman Fong, M.D., the Sangiacomo Family Chair in Surgical Oncology) and a clinical fellowship at Severance Hospital, Yonsei University, Seoul (mentored by Woo Jin Hyung, M.D., Ph.D.). She began her career as faculty at CUMC in the Division of GI and Endocrine Surgery where she initiated the robotic surgery program for complex abdominal cancers and established the Center for Global Excellence in Gastric Cancer Care. Subsequently, she was recruited to the Department of Surgery at City of Hope in 2015.

 

Armed with the trifecta of clinical, research and teaching capabilities, Dr. Woo is an unstoppable force spearheading our transformative programs in robotic cancer surgery and gastric cancer at City of Hope. She is an associate professor of surgery, director of international surgery and director of the Gastroenterology Minimally Invasive Therapy Program in the Division of Surgical Oncology, Department of Surgery. In collaboration with her national and international colleagues, her multidisciplinary team of clinicians, scientists, immunologists, and bioinformaticians at City of Hope investigates immune biomarkers for earlier detection of gastrointestinal cancers, translates novel targeted agents, such as oncolytic viruses, into effective diagnostic and therapeutic tools for cancer patients, and safely integrates advancements in surgical technologies to improve patient outcomes. Funded by the Department of Defense Idea Award, AACR's first SU2C Stomach Cancer Interception Award, the Ohr Foundation, and other generous donations to City of Hope, her ongoing contributions to the field are reflected in the growing number of publications in peer-reviewed manuscripts, authored textbook chapters and invited lectures.

 
Dr. Woo has been an active member of several national and international societies, including the Society of Surgical Oncology (SSO), Society of American Gastrointestinal and Endoscopic Surgeons, American College of Surgeons (ACS), Association of American Cancer Research, the AASCTF (Asian American Stomach Cancer Task Force) and G6+ (International GC Surgeon Collaborative). She also serves as a member of the International Committee of SSO, the Robotics Task Force of SAGES, director of the Complex Robotic Surgery Course at the annual congress of ACS, the executive committee of KAMA US, the executive board of KAGMA, and as co-chair of medical advisors for Hope for Stomach Cancer.
 
Dr. Woo's visionary insights and collaborative leadership is empowering multidisciplinary teamwork to speed the delivery of transformative cancer cures to our patients at City of Hope. Dr. Woo will continue to bring us closer to a cancer-free society as she strives to live up to her name which means bright (YANG) hope (HEE).

Location

Education & Experience

Degrees

  • 2003, Doctor of Medicine, Drexel College of Medicine, Philadelphia, Pennsylvania

  • 1998, Health Careers Program, Harvard University Extension School, Cambridge, Massachusetts

  • 1995, Certificate in East Asian Studies, Bachelor of Arts in Politics, Princeton University, Princeton, New Jersey

Fellowship

  • 2010-2011, Fellow, International Upper GI/Robotic Surgery Fellow, Department of Surgery, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea

  • 2005-2007, Research Fellow, Laboratory of Yuman Fong, M.D., Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

Residency

  • 2007-2010, General Surgery Resident, Department of Surgery, Columbia Presbyterian Medical Center, New York City, NY

  • 2003-2005, Intern/Resident, Department of Surgery, St. Vincent's Catholic Medical Centers

Professional Experience

  • 2015-present, Associate Professor, Division of Surgical Oncology, Department of Surgery, City of Hope, Duarte and Orange County, California

  • 2015-present, Director, Gastroenterology Minimally Invasive Therapy Program, City of Hope, Duarte, California

  • 2015-present, Director, International Surgery, City of Hope, Duarte, California

  • 2013–2015, Assistant Professor, Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, New York

  • 2011-2015, Director, Center for Global Excellence in Gastric Cancer Care, Columbia University, College of Physicians and Surgeons, New York, New York

Awards & Memberships

Awards

  • 2018, Community Empowerment Award, Korean American Federation of Los Angeles

Memberships

  • American College of Surgeons

  • Society of American Gastrointestinal and Endoscopic Surgeons

  • Clinical Robotic Surgery Assn

  • International Gastric Cancer Assn

  • Korean American Medical Assn

  • G-6+ International Robotic Gastric Cancer Surgeons Society

Publications

Peer-Reviewed Publications

Corresponding/Senior Author

  1. Yan Y, Yang A, Lu L, Zhao Z, Li C, Li W, Chao J, Liu T, Fong Y, Fu W, Woo Y. Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched Study. Ann Surg Oncol. 2021 Mar;28(3):1428-1436. doi: 10.1245/s10434-020-09070-9. Epub 2020 Aug 29. PMID: 32862371.
  2. Stewart C, Chao J, Chen YJ, Lin J, Sullivan MJ, Melstrom L, Hyung WJ, Fong Y, Paz IB, Woo Y. Multimodality management of locally advanced gastric cancer - the timing and extent of surgery. Transl Gastroenterol Hepatol. 2019 May 30;4:42. doi: 10.21037/tgh.2019.05.02. eCollection 2019. Review. PubMed PMID: 31231709; PubMed Central PMCID: PMC6556681.
  3. Stewart CL, Ituarte PHG, Melstrom KA, Warner SG, Melstrom LG, Lai LL, Fong Y, Woo Y. Robotic surgery trends in general surgical oncology from the National Inpatient Sample. Surg Endosc. 2018 Oct 24. [Epub ahead of print] PMID: 30357525.
  4. Desiderio J, Stewart CL, Sun V, Melstrom L, Warner S, Lee B, Schoellhammer HF, Trisal V, Paz B, Fong Y, Woo Y. Enhanced Recovery after Surgery for Gastric Cancer Patients Improves Clinical Outcomes at a US Cancer Center. J Gastric Cancer. 2018 Sep;18(3):230-241. PMID: 30276000
  5. Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, Parisi A, Woo Y. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer. 2017 Jul;79:1-14. PMID: 28456089

First Author

  1. Woo Y, Warner SG, Geha R, Stanford MM, Decarolis P, Rahman MM, Singer S, McFadden G, Fong Y. The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase. Clin Med Insights Oncol. 2021 Feb 11;15:1179554921993069. doi: 10.1177/1179554921993069. PMID: 33633477; PMCID: PMC7887694.
  2. Woo Y, Zhang Z, Yang A, Chaurasiya S, Park AK, Lu J, Kim SI, Warner SG, Von Hoff D, Fong Y. Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer. J Am Coll Surg. 2020 Apr;230(4):709-717. doi: 10.1016/j.jamcollsurg.2019.12.027. Epub 2020 Feb 4.
  3. Woo Y, Behrendt CE, Yang A, Hahn M, Goel A, Li H, Yuan YC, Fong Y. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients. J Am Coll Surg. 2021 Jan 17:S1072-7515(21)00010-7. doi: 10.1016/j.jamcollsurg.2020.12.023. Epub ahead of print. PMID: 33465468.
  4. Woo Y, Son T, Obama K. Global trends in the surgical management of gastric cancer. Transl Gastroenterol Hepatol. 2020 Jan 5;5:1. doi: 10.21037/tgh.2019.09.10. eCollection 2020.
  5. Woo Y, Reid V, Kelly KJ, Carlson D, Yu Z, Fong Y. Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer. Mol Ther Oncolytics. 2019 Dec 6;16:1-6. doi: 10.1016/j.omto.2019.11.003. eCollection 2020 Mar 27.
  6. Woo Y, Goldner B, Son T, Song K, Fong Y, Hyung WJ. Western Validation of a Novel Gastric Cancer Prognosis Prediction Model in US Gastric Cancer Patients. J Am Coll Surg. 2017 Dec 22.
  7. Woo Y, Behrendt CE, Trapp G, Hyun JG, Gonda T, Fong Y, Wang T. Screening endoscopy finds high prevalence of Helicobacter pylori and intestinal metaplasia in Korean American with limited access to health care. J Surg Oncol. 2017Aug;116(2):172-176.
  8. Woo Y, Goldner B, Ituarte P, Lee B, Melstrom L, Son T, Noh SH, Fong Y, Hyung WJ. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study. J Am Coll Surg. 2017 Apr;224(4):546-555.
  9. Woo Y, Son T, Song K, Okumura N, Hu Y, Cho GS, Kim JW, Choi SH, Noh SH, Hyung WJ. A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma: Development and Validation Using Asian Databases. Ann Surg. 2016 Jul;264(1):114-20. PMID: 26945155
  10. Woo Y, Choi GH, Min BS, Hyung WJ. Novel application of simultaneous multi-image display during complex robotic abdominal procedures. BMC Surg. 2014 Mar 15;14:13.
  11. Woo Y, Hyung WJ, Pak KH, Obama K, Noh SH. Successful cholecystectomy during robotic gastrectomy. Minim Invasive Ther Allied Technol. 2012 Jul;21(4):276-81. PMID: 22049943.
  12. Woo Y, Hyung WJ, Obama K, Kim HI, Pak KH, Son T, Noh SH. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. J Surg Oncol. 2012 Mar 15;105(4):405-9. PMID: 22025360.
  13. Woo Y, Hyung WJ, Kim HI, Obama K, Son T, Noh SH. Minimizing hepatic trauma with a novel liver retraction method: a simple liver suspension using gauze suture. Surg Endosc. 2011 Dec;25(12):3939-45. PMID: 21656069.
  14. Woo Y, Hyung WJ, Pak KH, Inaba K, Obama K, Choi SH, Noh SH. Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg. 2011 Sep;146(9):1086-92. PMID: 21576595.
  15. Kelly KJ and Woo Y (co-first authorship), Brader P, Yu Z, Riedl C, Lin SF, Chen N, Yu YA, Rusch VW, Szalay AA, Fong Y. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Hum Gene Ther. 2008 Aug;19(8):774-82.
  16. Woo Y, Kelly KJ, Stanford MM, Galanis C, Chun YS, Fong Y, McFadden G. Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells. Ann Surg Oncol. 2008 Aug;15(8):2329-35.

Collaborating Author

  1. Banapour P, Yuh B, Chenam A, Shen JK, Ruel N, Han ES, Kim JY, Maghami EG, Pigazzi A, Raz DJ, Singh GP, Wakabayashi M, Woo Y, Fong Y, Lau CS. Readmission and complications after robotic surgery: experience of 10,000 operations at a comprehensive cancer center. J Robot Surg. 2021 Feb;15(1):37-44. doi: 10.1007/s11701-020-01077-4. Epub 2020 Apr 10. PMID: 32277400.
  2. Kim SI, Park AK, Chaurasiya S, Kang S, Lu J, Yang A, Sivanandam V, Zhang Z, Woo Y, Priceman SJ, Fong Y, Warner SG. Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity. Mol Cancer Ther. 2021 Jan;20(1):173-182. doi: 10.1158/1535-7163.MCT-20-0405. Epub 2020 Dec 1. PMID: 33262221; PMCID: PMC7790874.
  3. Chaurasiya S, Yang A, Kang S, Lu J, Kim SI, Park AK, Sivanandam V, Zhang Z, Woo Y, Warner SG, Fong Y. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model. Oncoimmunology. 2020 Feb 24;9(1):1729300. doi: 10.1080/2162402X.2020.1729300. eCollection 2020.
  4. Banapour P, Yuh B, Chenam A, Shen JK, Ruel N, Han ES, Kim JY, Maghami EG, Pigazzi A, Raz DJ, Singh GP, Wakabayashi M, Woo Y, Fong Y, Lau CS. Readmission and complications after robotic surgery: experience of 10,000 operations at a comprehensive cancer center. J Robot Surg. 2020 Apr 10. doi:10.1007/s11701-020-01077-4
  5. Chaurasiya S, Chen NG, Lu J, Martin N, Shen Y, Kim SI, Warner SG, Woo Y, Fong Y. A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models. Cancer Gene Ther. 2020 Apr;27(3-4):125-135. doi: 10.1038/s41417-019-0114-x. Epub 2019 Jun 17.
  6. Marano A, Maione F, Woo Y, Pellegrino L, Geretto P, Sasia D, Fortunato M, Orcioni GF, Priotto R, Fasoli R, Borghi F. Robotic wedge resection of a rare gastric perivascular epithelioid cell tumor: A case report. World J Clin Cases. 2019 Dec 6;7(23):4011-4019. doi: 10.12998/wjcc.v7.i23.4011.
  7. Konstantinidis IT, Ituarte P, Woo Y, Warner SG, Melstrom K, Kim J, Singh G, Lee B, Fong Y, Melstrom LG.Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety. Surg Endosc. 2019 Dec 9. doi: 10.1007/s00464-019-07284-x.
  8. Son T, Sun J, Choi S, Cho M, Kwon IG, Kim HI, Cheong JH, Choi SH, Noh SH, Woo Y, Fong Y, Park S, Hyung WJ. Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database. J Surg Oncol. 2019 Sep;120(4):676-684. doi: 10.1002/jso.25639. Epub 2019 Jul 23.
  9. Callahan AF, Ituarte PHG, Goldstein L, Warner SG, Woo Y, Singh G, Fong Y, Melstrom LG. Prophylactic Pancreatectomies Carry Prohibitive Mortality at Low-Volume Centers: A California Cancer Registry Study. World J Surg. 2019 Sep;43(9):2290-2299. doi: 10.1007/s00268-019-05019-6. PubMed PMID: 31062057.
  10. Stewart CL, Dumitra S, Nota C, Ituarte PHG, Melstrom LG, Woo Y, Singh G, Fong Y, Nathan H, Warner SG. Hospital factors strongly influence robotic use in general surgery. Surgery. 2019 Jun 14. pii: S0039-6060(19)30247-8. doi 10.1016/j.surg.2019.05.008. [Epub ahead of print] PubMed PMID: 31208862.
  11. Callahan AF, Ituarte PHG, Goldstein L, Warner SG, Woo Y, Singh G, Fong Y, Melstrom LG. Prophylactic Pancreatectomies Carry Prohibitive Mortality at Low-Volume Centers: A California Cancer Registry Study. World J Surg. 2019 May 6. doi: 10.1007/s00268-019-05019-6. [Epub ahead of print] PubMed PMID:31062057.
  12. Warner SG, Kim SI, Chaurasiya S, O'Leary MP, Lu J, Sivanandam V, Woo Y, Chen NG, Fong Y. A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression. Mol Ther Oncolytics. 2019 Apr 11;13:82-92. doi: 10.1016/j.omto.2019.04.001. eCollection 2019 Jun 28. PubMed PMID: 31061881; PubMed Central PMCID: PMC6495072.
  13. Chaurasiya S, Chen NG, Lu J, Martin N, Shen Y, Kim SI, Warner SG, Woo Y, Fong Y. A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models. Cancer Gene Ther. 2019 Jun 17. [Epub ahead of print] PubMed PMID: 31209267.
  14. Stewart CL, Dumitra S, Nota C, Ituarte PHG, Melstrom LG, Woo Y, Singh G, Fong Y, Nathan H, Warner SG. Hospital factors strongly influence robotic use in general surgery. Surgery. 2019 Jun 14. [Epub ahead of print] PubMed PMID: 31208862.
  15. Callahan AF, Ituarte PHG, Goldstein L, Warner SG, Woo Y, Singh G, Fong Y, Melstrom LG. Prophylactic Pancreatectomies Carry Prohibitive Mortality at Low-Volume Centers: A California Cancer Registry Study. World J Surg. 2019 May 6. [Epub ahead of print] PMID: 31062057.
  16. Warner SG, Kim SI, Chaurasiya S, O'Leary MP, Lu J, Sivanandam V, Woo Y, Chen NG, Fong Y. A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression. Mol Ther Oncolytics. 2019
  17. Nota CLMA, Smits FJ, Woo Y, Borel Rinkes IHM, Molenaar IQ, Hagendoorn J, Fong Y. Robotic Developments in Cancer Surgery. Surg Oncol Clin N Am. 2019 Jan;28(1):89-100. Epub 2018 Oct 23. Review. PMID: 30414684.
  18. Nota CL, Woo Y, Raoof M, Boerner T, Molenaar IQ, Choi GH, Kingham TP, Latorre K, Borel Rinkes IHM, Hagendoorn J, Fong Y. Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study. Ann Surg Oncol. 2018 Oct 17. [Epub ahead of print] PMID: 30334196.
  19. Raoof M, Nota CLMA, Melstrom LG, Warner SG, Woo Y, Singh G, Fong Y. Oncologic outcomes after robot-assisted versus laparoscopic distal pancreatectomy: Analysis of the National Cancer Database. J Surg Oncol. 2018 Sep;118(4):651-656. PMID: 30114321.
  20. Li R, Hou WH, Chao J, Woo Y, Glaser S, Amini A, Nelson RA, Chen YJ. Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer. J Natl Compr Canc Netw. 2018 Aug;16(8):950-958. PMID: 30099371.
  21. Chuang J, Gong J, Klempner SJ, Woo Y, Chao J. Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification. J Gastrointest Oncol. 2018 Jun;9(3):560-572. PMID: 29998022
  22. O'Leary MP, Warner SG, Kim SI, Chaurasiya S, Lu J, Choi AH, Park AK, Woo Y, Fong Y, Chen NG. A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection. Mol Ther Oncolytics.
  23. Eng OS, Kim JY, Ruel N, Raz DJ, Erhunmwunsee L, Melstrom LG, Chao J, Woo Y, Kim J, Sun V. Quality of Life, Symptoms, and Self-Management Strategies After Gastroesophageal Cancer Surgery. J Pain Symptom Manage. 2018 Aug;56(2):e4-e8. PMID: 29753100.
  24. O'Leary MP, Choi AH, Kim SI, Chaurasiya S, Lu J, Park AK, Woo Y, Warner SG, Fong Y, Chen NG. Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose. J Transl Med. 2018 Apr 26;16(1):110. PMID: 29699566
  25. Slavin T, Neuhausen SL, Rybak C, Solomon I, Nehoray B, Blazer K, Niell-Swiller M, Adamson AW, Yuan YC, Yang K, Sand S, Castillo D, Herzog J, Wu X, Tao S, Chavez T, Woo Y, Chao J, Mora P, Horcasitas D, Weitzel J. Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network. Cancer Genet. 2017 Oct;216-217:111-119. PMID: 29025585
  26. Fong Y, Woo Y, Giulianotti PC. Robotic surgery: the promise and finally the progress. Hepatobiliary Surg Nutr. 2017 Aug;6(4):219-221. PMID: 28848743
  27. Dalal KM, Woo Y, Kelly K, Galanis C, Gonen M, Fong Y, Coit DG. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer. 2008;11(4):206-13. PMID: 19132482.

Textbook Contributions:

  1. Fong Y, Woo, Y, Lau C, Hyung, WJ, Strong V (Eds). SAGES Atlas of Robotic Surgery, 1st Edition (2018). New York, NY, Springer. a. Lewis A, Woo Y, Fong Y(2018). Hybrid Robot-Assisted Surgery in SAGES Atlas of Robotic Surgery. b. Woo Y. (2018).
  2. Woo Y. (2018). Total Gastrectomy for Cancer in Atlas of Robotic Surgery, 1st Ed. Kudsi, Carbonelli, Yiengpruksawan, Jones (Eds). Woodbury, CT. Cine-Med, Inc.
  3. Woo Y, Fong Y. Chapter 8 Robotic GI Surgery in 13th Ed Edited by Michael J Zinner and Stanley W. Ashley. In Print.
  4. Gonda T, Woo Y. Chapter 60 “Miscellaneous Diseases of the Stomach,” in Yamada’s Textbook of Gastroenterology. Ed by Tadataka Yamada. Wiley Blackwell. 2014
  5. Obama K, Woo Y, Hyung WJ. Chapter "Robotic Assisted Gastrectomy with Lymph Node Dissection”, Master Techniques in General Surgery: Foregut Surgery, by Michael Nussbaum, MD and James Luketich, MD. Lippincott Williams & Wilkins 2013.
  6. Woo Y. Chapter “Robotic Cholecystectomy,” Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery. 2nd Edition by Clavien, Sarr, Myazaki, Fong: Springer In print
  7. Hyung WJ, Woo Y. Chapter “Robotic Gastrectomy for Gastric Cancer,” Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery. 2nd Edition.  By Clavien, Sarr, Myazaki, Fong: Springer In print
  8. Hyung WJ, Woo Y. Chapter 9 “ Robotic Surgery for Gastric Cancer,” Robotics in General Surgery. 1st Edition. By Keith Chae Kim: Springer. 2014
  9. Woo Y. Chapter 6. Liver, Biliary System, and Spleen. First Aid for the ABSITE, 1st Ed.  New York: McGraw-Hill, 2008.


Invited Lectures:

  1. “Starting a Robotic Gastric Cancer Program,” “Video Presentation of Lessons Learned from First Robotic Gastrectomy D2 Lymphadenectomy,” and “Does the Size of an Incision Make a Difference” at the 11th IGCC, Sao Paulo, Brazil, June 4-6, 2015
  2. “Update on Gastric Cancer Treatment,” Holy Name Medical Center CME course. Englewood Cliffs, NJ USA Sept. 23, 2014
  3. “Gastric Cancer, a Disease of Ethnic Disparities,” KAMA National Convention, Honolulu, Hawaii. USA August 6, 2014
  4. “Minimally Invasive Surgery for Gastric Cancer,” Third Annual Peter Stephens Symposium on Innovations in Digestive Care Course, New York, NY USA, April 10, 2014
  5. “Advances in Surgery for Gastric Cancer,” Second Annual Update on Gastrointestinal Cancers, New York, NY USA September 27, 2103
  6. “Robotic Gastric Cancer Surgery for the Obese and Aged,” 7th International Symposium of Yonsei Live/ World Robotic Society Meeting, Seoul Korea, August 2013
  7. “Robotics in Advanced Abdominal Cancer Surgery,” John Jones Society’s 13th Annual Spring Meeting, New Technology in Surgery. New York, NY USA May 10, 2013
  8. “Gastric Cancer in North America,” First PanAmerican Congress of Gastric Cancer, Porto Alegre, Brazil, September 6-9, 2012
  9. “Robotic Gastric Cancer Surgery in Americans,” 6th International Symposium of Yonsei Live/ World Robotic Society Meeting – 2012, Seoul Korea, August 2012
  10. “Starting a Robotic Surgical Oncology Program,” 5th International Symposium of Multi-specialty Live Surgery – Yonsei Live 2011, Seoul, Korea. August 25-27, 2011

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Recommend this provider office
5.0
Show respect for what you say
4.9
Provider listen carefully to you
4.9
Know important info medical history
4.9
Spend enough time with you
4.9
Rate provider 0-10
4.8
Provider explain in way you understand
11/10/24
Very good - Verified patient
11/10/24
Very good [...] - Verified patient
10/15/24
Dr Woo is simply tge BEST - Verified patient
09/10/24
Dr. Woo is very kind and listen to me and my concerns and explained so much to me, and took her time. I did not feel rushed. - Verified patient
08/20/24
Great experience - Verified patient